Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262210832 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sun Ho Min und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, AMP-Activated Protein Kinases, Signal Transduction, Lipoxins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Women in Science, Engineering, and Technology (WISET) Returners into R&D Program, Ministry of Science and ICT (MSIT), and faculty research grants from Yonsei University College of Medicine.
Abstract (Originalsprache)
Radiation-induced lung inflammation (RILI) is a major complication of thoracic radiotherapy, characterized by excessive inflammation and subsequent fibrosis that compromise pulmonary function and treatment outcomes. This study explores the pharmacological properties of a newly synthesized Lipoxin A4 analogue (CYNC-2) to mitigate RILI by modulating the AMP-activated protein kinase (AMPK)/NOD-like receptor family pyrin domain containing 3(NLRP3) inflammasome pathway. A murine RILI model was established in mice by delivering a single high-dose (ablative) X-ray irradiation to the left lung. Mice in the treatment group received CYNC-2 via tail-vein injection three times per week for 2 weeks. The effects of CYNC-2 on RILI were evaluated histological, immunohistochemical analysis of lung tissues, cytokine profiling, lung function testing using a FlexiVent system, and micro-computed tomography (micro-CT) imaging of lung damage. In parallel, two human lung cell lines—L132 (normal bronchial epithelial cells) and A549 (lung carcinoma cells)—were irradiated with 6 Gy X-rays and treated with CYNC-2 to assess cell viability and changes in AMPK/NLRP3 pathway markers via qPCR and immunofluorescence. Lung tissue sample from patients who underwent thoracic radiotherapy were also examined to validate key findings. CYNC-2 activated AMPK and inhibited mTOR signaling, which suppressed NLRP3 inflammasome activation and led to reduced secretion of pro-inflammatory cytokines (IL-1β, IL-6, and TGF-β1). In vitro, CYNC-2 mitigated radiation-induced inflammatory responses and preserved cellular viability. Overall, CYNC-2 effectively dampened acute pulmonary in the RILI model. These findings suggest that targeting the AMPK/NLRP3 inflammasome pathway via a stable LXA4 analogue such as CYNC-2 is a promising therapeutic strategy to improve clinical outcomes for patients receiving thoracic radiation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- College of Pharmacy, CHA University, Pocheon-si 11160, Gyeonggi-do, Republic of Korea.
- Department of Food and Nutrition, College of Health Science, Honam University, Gwangju 62399, Republic of Korea.
ORCID-Profile: Ronglan Cui, Sang Yeon Kim, Younghwa Na, Jaeho Cho
Förderung
- National Research Foundation of Korea
- Women in Science, Engineering, and Technology (WISET) Returners into R&D Program
- Ministry of Science and ICT (MSIT), and faculty research grants from Yonsei University College of Medicine
Zitieren
APA
Min, S. H., Shin, J. H., Park, S., Cui, R., Hur, Y. J., Jeong, W. H., Kim, S. Y., Na, Y., & Cho, J. (2025). Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210832
Vancouver
Min SH, Shin JH, Park S, Cui R, Hur YJ, Jeong WH, et al. Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210832
BibTeX
@article{Min2025,
author = {Min, Sun Ho and Shin, Jae-Ho and Park, Sunjoo and Cui, Ronglan and Hur, Youn Ji and Jeong, Woo Hyun and Kim, Sang Yeon and Na, Younghwa and Cho, Jaeho},
title = {Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262210832}
}
EUVIMED